Skip to main content

Symptom Control

  • Chapter
  • First Online:
Palliative Care in Clinical Practice
  • 2077 Accesses

Abstract

Symptoms are the patient’s perceptions of abnormal physiological changes due to the disease or its treatment. As symptoms are dynamic and can change over time, their management is central to the practice of palliative care. It is important to make a diagnosis of the underlying mechanisms or causes of the symptom, individualize the treatment, and, where possible, keep the management simple (Figure 4.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Potter J, Hami F, Bryan T, Quigley C. Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med. 2003;17:310–4.

    Article  PubMed  Google Scholar 

  2. Chang VT. Tools for pain and symptom assessment in palliative care. In: Bruera E, Higginson IJ, Ripamonti C, von Gunten C, editors. Textbook of palliative medicine. London: Hodder Arnold; 2006. p. 333–48.

    Google Scholar 

  3. Dunn A, Carter J, Carter H. Anemia at the end of life: prevalence, significance and causes in patients receiving palliative care. J Pain Symptom Manage. 2003;26:1132–329.

    Article  PubMed  Google Scholar 

  4. Turner AR. Clinical management of anaemia, cytopenias, and thrombosis in palliative care. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 928–33.

    Google Scholar 

  5. Hirst B. Management of anemia in palliative care. MIMS oncology & palliative care. 2009. Available at: www.healthcarerepublic.com/News/EmailThisArticle/915238/Management-anaemia-palliative-care. Last accessed 27 Nov 2011.

  6. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol. 2005;18:319–32.

    Article  PubMed  CAS  Google Scholar 

  7. British National Formulary. BNF 61. London: BMJ Group and Pharmaceutical Press; 2011. Available at: www.bnf.org. Last accessed 27 Nov 2011.

  8. Bohlius J, Wilson J, Seidenfeld WJ, et al. Erythropoietin or darbopoietin for patients with cancer. Cochrane Database Syst Rev. 2006;(3):CD003407.

    Google Scholar 

  9. Gleeson C, Spencer D. Blood transfusion and its benefits in palliative care. Palliat Med. 1995;9:307–13.

    Article  PubMed  CAS  Google Scholar 

  10. Nelson KA. Modern management of the cancer anorexia–cachexia syndrome. Curr Pain Headache Rep. 2001;5:250–6.

    Article  PubMed  CAS  Google Scholar 

  11. MacDonald N. Anorexia–cachexia syndrome. Eur J Palliat Care. 2005;12:8–14.

    Google Scholar 

  12. Fearon KCH, Baracos V, Watanabe S. Classification, clinical assessment and treatment of the anorexia–cachexia syndrome. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 908–15.

    Google Scholar 

  13. NHS Scotland. Palliative care guidelines – symptom control – anorexia. 2009. Available at: www.palliativecareguidelines.scot.nhs.uk/documents/Anorexia.pdf. Last accessed 27 Nov 2011.

  14. Loprinzi CL, Michalak JC, Schaid DJ, et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol. 1993;11:762–7.

    PubMed  CAS  Google Scholar 

  15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: APA; 2000.

    Google Scholar 

  16. Stoklosa J, Patterson K, Rosielle D, Arnold R. Anxiety in palliative care – causes and diagnosis. J Palliat Med. 2011;14:1173–4.

    Article  PubMed  Google Scholar 

  17. Roth AJ, Massie MJ. Anxiety and its management in advanced cancer. Curr Opin Support Palliat Care. 2007;1:50–6.

    Article  PubMed  Google Scholar 

  18. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

    Article  PubMed  CAS  Google Scholar 

  19. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychological distress in ambulatory cancer patients. Cancer. 2005;103:1494–502.

    Article  PubMed  Google Scholar 

  20. Breitbart W, Chochinov HM, Passik SD. Psychiatric symptoms in palliative medicine. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 1453–82.

    Google Scholar 

  21. Anderson T, Watson M, Davidson R. The use of cognitive behavioural therapy techniques for anxiety and depression in hospice patients: a feasibility study. Palliat Med. 2008;22:814–21.

    Article  PubMed  CAS  Google Scholar 

  22. Runyon BA. Care of patients with ascites. N Engl J Med. 1994;330:337–42.

    Article  PubMed  CAS  Google Scholar 

  23. Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18:945–9.

    Article  PubMed  CAS  Google Scholar 

  24. Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer. 2006;42:589–97.

    Article  PubMed  Google Scholar 

  25. Chan KS, Tse MW, Sham MMK, Thorsen AB. Palliative medicine in malignant respiratory disease. In: Hanks G, Cherny N, Kaasa S, editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 1107–44.

    Google Scholar 

  26. Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med. 2007;21:177–91.

    Article  PubMed  Google Scholar 

  27. Jennings AL, Davies AN, Higgins JPT, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939–44.

    Article  PubMed  Google Scholar 

  28. Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2010;(1):CD 007354.

    Google Scholar 

  29. Booth S, Anderson H, Swannick M, et al. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the scientific committee of the association of palliative medicine. Respir Med. 2003;98:66–77.

    Article  Google Scholar 

  30. Bredin M, Corner J, Krishnasamy M, et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999;318:901–4.

    Article  PubMed  CAS  Google Scholar 

  31. Sachs S, Weinberg RL. Pulmonary rehabilitation for dyspnea in the palliative-care setting. Curr Opin Support Palliat Care. 2009;3:112–9.

    Article  PubMed  Google Scholar 

  32. Fallon M, O’Neill B. ABC of palliative care. Constipation and diarrhoea. BMJ. 1997;315:1293–6.

    Article  PubMed  CAS  Google Scholar 

  33. Clemens K, Klaschik E. Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide. Ther Clin Risk Manag. 2010;6:77–82.

    Article  PubMed  CAS  Google Scholar 

  34. Sykes N. Constipation and diarrhoea. In: Hanks G, Cherny N, Kaasa S, editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 833–50.

    Google Scholar 

  35. Rentz AM, van Hanswijck de Jonge P, Leyendecker P, Hopp M. Observational, nonintervention, multicenter study for validation of the Bowel Function Index for constipation in European countries. Curr Med Res Opin. 2011;27:35–44.

    Article  PubMed  CAS  Google Scholar 

  36. Larkin PJ, Sykes NP, Centeno C, et al. The management of constipation in palliative care: clinical practice recommendations. Palliat Med. 2008;22:796–807.

    Article  PubMed  CAS  Google Scholar 

  37. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008;358:2332–43.

    Article  PubMed  CAS  Google Scholar 

  38. Piirilä P, Sovijärvi AR. Objective assessment of cough. Eur Respir J. 1995;8:1949–56.

    Article  PubMed  Google Scholar 

  39. Symptom management. In: Watson M, Lucas C, Hoy A, Back I, editors. Oxford handbook of palliative care. Oxford: Oxford University Press; 2005:363–380.

    Google Scholar 

  40. Irwin RS, French CT, Fletcher KE. Quality of life in coughers. Pulm Pharmacol Ther. 2002;15:283–6.

    Article  PubMed  CAS  Google Scholar 

  41. Molassiotis A, Smith JA, Bennett MI, et al. Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough. Cough. 2010;6:9.

    Article  PubMed  Google Scholar 

  42. Birring SS, Prudon B, Carr AJ, et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58:339–43.

    Article  PubMed  CAS  Google Scholar 

  43. French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality-of-life questionnaire. Chest. 2002;121:1123–31.

    Article  PubMed  Google Scholar 

  44. Wee B. Chronic cough. Curr Opin Support Palliat Care. 2008;2:105–9.

    Article  PubMed  Google Scholar 

  45. Bonneau A. Cough in the palliative care setting. Can Fam Physician. 2009;55:600–2.

    PubMed  Google Scholar 

  46. Estfan B, LeGrand S. Management of cough in advanced cancer. J Support Oncol. 2004;2:523–7.

    PubMed  Google Scholar 

  47. Davis C, Percy G. Breathlessness, cough, and other respiratory symptoms. In: Fallon M, Hanks G, editors. ABC of palliative care. 2nd ed. Oxford: Blackwell Publishing; 2006. p. 13–6.

    Google Scholar 

  48. NHS Scotland. Delirium. 2009. Available at: www.palliativecareguidelines.scot.nhs.uk/documents/Delirium.pdf. Last accessed 27 Nov 2011.

  49. Alici Y, Breibart W. Delirium in palliative care. Prim Psychiatry. 2009;16:42–8.

    Google Scholar 

  50. National Institute for Health and Clinical Excellence. Delirium. Diagnosis, prevention and management. NICE clinical guidelines 103. London: National Clinical Guideline Centre for Acute and Chronic Conditions; 2010.

    Google Scholar 

  51. Leonard M, Raju B, Conroy M, et al. Reversibility of delirium in terminally ill patients and predictors of mortality. Palliat Med. 2008;22:848–54.

    Article  PubMed  CAS  Google Scholar 

  52. Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med. 2004;18:184–94.

    Article  PubMed  Google Scholar 

  53. Cohen MZ, Pace EA, Kaur G, Bruera E. Delirium in advanced cancer leading to distress in patients and family caregivers. J Palliat Care. 2009;25:164–71.

    PubMed  Google Scholar 

  54. Palliative Drugs. Essential independent drug information for palliative and hospice care. Formulary 2011. Available at: www.palliativedrugs.com. Last accessed 27 Nov 2011.

  55. Cherny NI, Radbruch L, Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23:581–93.

    Article  PubMed  Google Scholar 

  56. World Health Organization. Mental health: depression. 2011. Available at: www.who.int/mental_health/management/depression/definition/en. Last accessed 27 Nov 2011.

  57. Noorani NH, Mantagnini M. Recognizing depression in palliative care patients. J Palliat Med. 2007;10:458–64.

    Article  PubMed  Google Scholar 

  58. Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians – American Society of Internal Medicine. Ann Intern Med. 2000;132:209–18.

    PubMed  CAS  Google Scholar 

  59. Chochinov HM, Wilson KG, Enns M, et al. Desire for death in the terminally ill. Am J Psychiatry. 1995;152:1185–91.

    PubMed  CAS  Google Scholar 

  60. Montano CB. Recognition and treatment of depression in a primary care setting. J Clin Psychiatry. 1994;55 suppl 12:S18–34.

    Google Scholar 

  61. Ellen SR, Norman TR, Burrows GD. MJA practice essentials. 3. Assessment of anxiety and depression in primary care. Med J Aust. 1997;167:328–33.

    PubMed  CAS  Google Scholar 

  62. Rayner L, Higginson IJ, Price A, Hotopf M. The management of depression in palliative care: draft European clinical guidelines. London: Department of Palliative Care, Policy & Rehabilitation/European Palliative Care Research Collaborative; 2009.

    Google Scholar 

  63. Rayner L, Loge JH, Wasteson E, Higgson IJ. The detection of depression in palliative care. Curr Opin Support Palliat Care. 2009;3:55–60.

    Article  PubMed  Google Scholar 

  64. Price A, Hotopf M. The treatment of depression in patients with advanced cancer undergoing palliative care. Curr Opin Support Palliat Care. 2009;3:61–6.

    Article  PubMed  Google Scholar 

  65. Wilkinson SM, Love SB, Westcombe AM, et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol. 2007;25:532–9.

    Article  PubMed  Google Scholar 

  66. National institute for Health and Clinical Excellence. Depression with a chronic physical health problem: full guideline CG91. 2009. Available at: www.nice.org.uk/nicemedia/live/12327/45913/45913.pdf. Last accessed 27 Nov 2011.

  67. Sykes N, Ripamonti C, Bruera E, Gordon D. Constipation, diarrhoea and intestinal obstruction. In: Fallon M, Hanks G, editors. ABC of palliative care. 2nd ed. Oxford: Blackwell Publishing; 2006. p. 29–35.

    Google Scholar 

  68. Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol. 2004;2:467–79.

    PubMed  Google Scholar 

  69. Davies AN. Oral symptoms. In: Sykes N, Edmonds P, Wiles J, editors. Management of advanced disease. 4th ed. London: Arnold; 2006. p. 168–74.

    Google Scholar 

  70. Lew J, Smith JA. Mucosal graft-vs-host disease. Oral Dis. 2007;13:519–29.

    Article  PubMed  CAS  Google Scholar 

  71. Bhide SA, Miah AB, Harrington KJ, Newbold KL, Nutting CM. Radiation-induced xerostomia: pathophysiology, prevention and treatment. Clin Oncol. 2009;21:737–44.

    Article  CAS  Google Scholar 

  72. De Conno F, Martini C, Sbanotto A, Ripamonti C, Ventafridda V. Mouth care. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 996–1014.

    Google Scholar 

  73. World Gastroenterology Organisation. Practice guidelines. Dysphagia. 2007. Available at: www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/08_dysphagia.pdf. Last accessed 27 Nov 2011.

  74. Swann D, Edmonds P. Dysphagia. In: Sykes N, Edmonds P, Wiles J, editors. Management of advanced disease. 4th ed. London: Arnold; 2006. p. 136–45.

    Google Scholar 

  75. Regnard C. Dysphagia, dyspepsia and hiccup. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 812–33.

    Google Scholar 

  76. Porter SR, Scully C. Oral malodour (halitosis). BMJ. 2006;333:632–5.

    Article  PubMed  CAS  Google Scholar 

  77. van den Broek AM, Feenstra L, de Baat C. A review of the current literature on aetiology and measurement methods of halitosis. J Dent. 2007;35:627–35.

    Article  PubMed  Google Scholar 

  78. Yaegaki K, Coil JM. Examination, classification and treatment of halitosis: clinical perspectives. J Can Dent Assoc. 2000;66:257–61.

    PubMed  CAS  Google Scholar 

  79. Bagg J, Davies A. Oral health in patients with advanced disease. In: Fallon M, Hanks G, editors. ABC of palliative care. 2nd ed. Oxford: Blackwell Publishing; 2006. p. 17–20.

    Google Scholar 

  80. Krakauer EL, Zhu AX, Bounds BC, et al. Case 6–2005. A 58-year-old man with oesophageal cancer and nausea, vomiting, and intractable hiccups. N Engl J Med. 2005;352:817–25.

    Article  PubMed  CAS  Google Scholar 

  81. Perdue C, Lloyd E. Managing persistent hiccups in advanced cancer 1: physiology. Nurs Times. 2008;104:24–5.

    PubMed  Google Scholar 

  82. Perdue C, Lloyd E. Managing persistent hiccups in advanced cancer 2: treatment. Nurs Times. 2008;104:20–1.

    PubMed  Google Scholar 

  83. Hardy J. The treatment of hiccups in terminal patients. Eur J Palliat Care. 2003;10:192–3.

    Google Scholar 

  84. Malone M, Harris AL, Luscombe DK. Assessment of the impact of cancer on work, recreation, home management and sleep using a general health status measure. J R Soc Med. 1994;87:386–9.

    PubMed  CAS  Google Scholar 

  85. Mercadante S, Girelli D, Casuccio A. Sleep disorders in advanced cancer patients: prevalence and factors associated. Supp Care Cancer. 2004;12:355–9.

    Article  Google Scholar 

  86. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbances in cancer patients. Soc Sci Med. 2002;54:1309–21.

    Article  PubMed  Google Scholar 

  87. Sateia MJ, Byock IR. Sleep in palliative care. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 1059–83.

    Google Scholar 

  88. Hugel H, Ellershaw JE, Cook L, et al. The prevalence, key causes and management of insomnia in palliative care patients. J Pain Symptom Manage. 2004;27:316–21.

    Article  PubMed  Google Scholar 

  89. Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev. 2011;15:99–106.

    Article  PubMed  Google Scholar 

  90. Savard J, Simard S, Ivers H, et al. Randomized study on the efficacy of cognitive – behavioral therapy for insomnia: part I: sleep and psychological effects. J Clin Oncol. 2005;23:6083–96.

    Article  PubMed  Google Scholar 

  91. Waller A, Caroline NL. Handbook of palliative care in cancer. Woburn: Butterworth-Heinemann; 2000. p. 115–24.

    Google Scholar 

  92. Zylicz Z, Krajnik M. Pruritus in the course of malignancy. In: Misery L, Ständer S, editors. Pruritus. London: Springer; 2010.

    Google Scholar 

  93. Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. Q J Med. 2003;96:7–26.

    Article  CAS  Google Scholar 

  94. Pittelkow MR, Loprinzi CL. Pruritus and sweating in palliative medicine. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 934–51.

    Google Scholar 

  95. Borup Christensen S, Lundgren E. Sequelae of axillary dissection vs. axillary sampling with or without irradiation for breast cancer. A randomized trial. Acta Chir Scand. 1989;155:515–9.

    PubMed  CAS  Google Scholar 

  96. Moffat CJ, Franks PJ, Doherty DC, et al. Lymphoedema: an underestimated health problem. Q J Med. 2003;96:731–8.

    Article  Google Scholar 

  97. International Society of Lymphology. Consensus document. The diagnosis and treatment of peripheral lymphedema. Lymphology. 2003;36:84–91.

    Google Scholar 

  98. Williams AF, Franks PJ, Moffat CJ. Lymphoedema: estimating the size of the problem. Palliat Med. 2005;19:300–13.

    Article  PubMed  Google Scholar 

  99. Keeley V. Lymphoedema. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 972–82.

    Google Scholar 

  100. Engel J, Kerr J, Schlesinger-Raab A, et al. Predictors of quality of life of breast cancer patients. Acta Oncol. 2003;42:710–8.

    Article  PubMed  Google Scholar 

  101. Sitzia J, Sobrido L. Measurement of health-related quality of life of patients receiving conservative treatment for limb lymphoedema using the Nottingham Health Profile. Qual Life Res. 1997;6:373–84.

    Article  PubMed  CAS  Google Scholar 

  102. Badger C, Preston NJ, Seers K, Mortimer P. Benzo-pyrones for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev. 2004;(2):CD003140.

    Google Scholar 

  103. Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008;44:1105–15.

    Article  PubMed  Google Scholar 

  104. Downing GM. Bowel obstruction. In: Downing GM, Wainwright W, editors. Medical care of the dying. 4th ed. Victoria: Victoria Hospice Society Learning Centre for Palliative Care; 2006. p. 333–9.

    Google Scholar 

  105. Letizia M, Norton E. Successful management of malignant bowel obstruction. J Hosp Palliat Nurs. 2003;5:152–8.

    Article  Google Scholar 

  106. Edmonds P, Wiles J. Pleural effusions. In: Sykes N, Edmonds P, Wiles J, editors. Management of advanced disease. 4th ed. London: Arnold; 2006. p. 289–93.

    Google Scholar 

  107. Musani AI. Treatment options for malignant pleural effusion. Curr Opin Pulm Med. 2009;15:380–7.

    Article  PubMed  Google Scholar 

  108. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65 suppl 2:ii32–40.

    Article  PubMed  Google Scholar 

  109. Woodruff R. Palliative medicine. 4th ed. Melbourne: Oxford University Press; 2004.

    Google Scholar 

  110. Moffett PU, Moffett BK, Laber DA. Diagnosing and managing suspected malignant pleural effusions. J Support Oncol. 2009;7:143–6.

    PubMed  Google Scholar 

  111. Maida V, Ennis M, Kuziemsky C, Trozzolo L. Symptoms associated with malignant wounds: a prospective case series. J Pain Symptom Manage. 2009;37:206–11.

    Article  PubMed  Google Scholar 

  112. Naylor W. Malignant wounds: aetiology and principles of management. Nurs Stand. 2002;16:45–56.

    PubMed  Google Scholar 

  113. McDonald A, Lesage P. Palliative management of pressure ulcers and malignant wounds in patients with advanced illness. J Palliat Med. 2006;9:285–95.

    Article  PubMed  Google Scholar 

  114. World Health Organization. Cancer pain relief. 2nd ed. Geneva: WHO; 1996.

    Google Scholar 

  115. Zeppetella G. Topical opioids for painful skin ulcers: does it work? Eur J Palliat Care. 2004;11:93–6.

    Google Scholar 

  116. Morgan D. Wounds – what should a dressing formulary include? Hosp Pharm. 2002;9:261–6.

    Google Scholar 

  117. Grocott P. Care of patients with fungating malignant wounds. Nurs Stand. 2007;21:57–66.

    PubMed  Google Scholar 

  118. Wilson V. Assessment and management of fungating wounds: a review. Br J Commun Nurs. 2005;10 suppl 3:S28–34.

    Google Scholar 

  119. Grocott P, Robinson V. Skin problems in palliative care – nursing perspective. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 961–72.

    Google Scholar 

  120. Potter JM, Reid DB, Shaw RJ, et al. Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs. BMJ. 1989;299:150–3.

    Article  PubMed  CAS  Google Scholar 

  121. Sweeney C, Bruera ED. Opioid side effects and management. In: Bruera ED, Porternoy RK, editors. Cancer pain assessment and management. Cambridge: Cambridge University Press; 2003. p. 150–70.

    Chapter  Google Scholar 

  122. Rhodes VA, McDaniel RW. Nausea, vomiting, and retching: complex problems in palliative care. CA Cancer J Clin. 2001;51:232–48.

    Article  PubMed  CAS  Google Scholar 

  123. Vainio A, Auvinen A. Symptom Prevalence Group. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage. 1996;12:3–10.

    Article  PubMed  CAS  Google Scholar 

  124. Fainsinger R, Miller MJ, Bruera E, et al. Symptom control during the last week of life on a palliative care unit. J Palliat Care. 1991;7:5–11.

    Google Scholar 

  125. Mannix K. Nausea and vomiting. In: Fallon M, Hanks G, editors. ABC of palliative care. 2nd ed. Oxford: Blackwell Publishing; 2006. p. 25–8.

    Google Scholar 

  126. Patient UK. Nausea and vomiting in palliative care. 2011. Available at: www.patient.co.uk/doctor/Nausea-and-Vomiting-in-Palliative-Care.htm. Last accessed 27 Nov 2011.

  127. Twycross R. Anorexia, cachexia, nausea and vomiting. Medicine. 2004;32:9–13.

    Article  Google Scholar 

  128. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437–49.

    Article  Google Scholar 

  129. Twycross R, Lack S. Symptom control in far advanced cancer. London: Pitman; 1983.

    Google Scholar 

  130. Diagnosing neuropathic pain in clinical practice. In: Bennett MI, editor. Neuropathic pain. Oxford: Oxford University Press; 2006:25–35.

    Google Scholar 

  131. Bennett M. The LANSS pain scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147–57.

    Article  PubMed  CAS  Google Scholar 

  132. Levy MH. Pharmacologic treatment of cancer pain. N Engl J Med. 1996;335:1124–32.

    Article  PubMed  CAS  Google Scholar 

  133. Hanks GW, De Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84:587–93.

    Article  PubMed  CAS  Google Scholar 

  134. Scottish Intercollegiate Guidelines Network. Control of pain in adults with cancer. A national clinical guideline. Edinburgh: SIGN; 2008.

    Google Scholar 

  135. Zeppetella G. Alternative routes for opioid administration. In: Forbes K, editor. Opioids for cancer pain. Oxford: Oxford University Press; 2007. p. 101–9.

    Google Scholar 

  136. Palliative Drugs. Buprenorphine. Available at: www.palliativedrugs.com/buprenorphine.html. Last accessed 27 Nov 2011.

  137. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19:2542–54.

    PubMed  CAS  Google Scholar 

  138. Fallon M, Hanks G, Charney N. Principles of control of cancer pain. In: Fallon M, Hanks G, editors. ABC of palliative care. 2nd ed. Oxford: Blackwell Publishing; 2006. p. 4–7.

    Google Scholar 

  139. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129–38.

    PubMed  CAS  Google Scholar 

  140. Zeppetella G, Bates C. Scientific evidence and expert clinical opinion for the clinical utility of opioid switching. In: Hillier R, Finlay I, Miles A, editors. The effective management of cancer pain. 2nd ed. London: Aesculapius Medical Press; 2002. p. 39–55.

    Google Scholar 

  141. International Association for the Study of Pain. Barriers to cancer pain treatment. 2009. Available at: www.iasp-pain.org/AM/Template.cfm?Section=Home&Template=/CM/ContentDisplay.cfm&ContentID=7189. Last accessed 27 Nov 2011.

  142. MIMS. Monthly Index of Medical Specialities. Available at: www.mims.co.uk/Tables/940779/Co-Analgesics-Use-Cancer-Pain. Last accessed 27 Nov 2011.

  143. Kohn M. The State of CAM in UK cancer care: advances in research, practice and delivery. Available at: www.cancer.gov/cam/attachments/cam-in-uk-summary.pdf. Last accessed 27 Nov 2011.

  144. Davies AN, Dickman A, Reid C, et al. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain. 2009;13:331–8.

    Article  PubMed  Google Scholar 

  145. Zeppetella G, Ribeiro MD. The pharmacotherapy of cancer-related episodic pain. Expert Opin Pharmacother. 2003;4:493–502.

    Article  PubMed  CAS  Google Scholar 

  146. Zeppetella G. Impact and management of breakthrough pain in cancer. Curr Opin Support Palliat Care. 2009;3:1–6.

    Article  PubMed  Google Scholar 

  147. Zeppetella G. Oral transmucosal opioid drugs. In: Davies A, editor. Cancer-related breakthrough pain. Oxford: Oxford University Press; 2006. p. 57–71.

    Google Scholar 

  148. Zeppetella G. Successful management of breakthrough pain in cancer patients. London: Evolving Medicine Ltd; 2011.

    Google Scholar 

  149. Davies A. General principles of management. In: Davies A, editor. Cancer-related breakthrough pain. Oxford: Oxford University Press; 2006. p. 31–42.

    Chapter  Google Scholar 

  150. Daniel WJ. Anorectal pain, bleeding and lumps. Aust Fam Physician. 2010;39:376–81.

    PubMed  Google Scholar 

  151. Mercadante S, Fulfaro F, Dabbene M. Methadone in treatment of tenesmus not responding to morphine escalation. Support Care Cancer. 2001;9:129–30.

    Article  PubMed  CAS  Google Scholar 

  152. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 1999;85:2103–13.

    Article  PubMed  CAS  Google Scholar 

  153. McGuire DB, Altomonte V, Peterson DE, et al. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum. 1993;20:1493–502.

    PubMed  CAS  Google Scholar 

  154. Brown CG, Yoder LH. Stomatitis: an overview. Am J Nurs. 2002;102 suppl 4:20–3.

    Article  PubMed  Google Scholar 

  155. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979.

    Google Scholar 

  156. Worthington HV, Clarkson JE, Bryan G, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2010;(12):CD000978.

    Google Scholar 

  157. Vayne-Bossert P, Escher M, de Vautibault CG, et al. Effect of topical morphine (mouthwash) on oral pain due to chemotherapy- and/or radiotherapy-induced mucositis: a randomized double-blinded study. J Palliat Med. 2010;13:125–8.

    Article  PubMed  Google Scholar 

  158. Clarkson JE, Worthington HV, Furness S, et al. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2010;(8):CD001973.

    Google Scholar 

  159. Swann D, Edmonds P. Sweating. In: Sykes N, Edmonds P, Wiles J, editors. Management of advanced disease. 4th ed. London: Arnold; 2006. p. 214–8.

    Google Scholar 

  160. Cheshire WP, Freeman R. Disorders of sweating. Semin Neurol. 2003;23:399–406.

    Article  PubMed  Google Scholar 

  161. Stolman LP. Treatment of hyperhidrosis. J Drugs Dermatol. 2003;2:521–7.

    PubMed  Google Scholar 

  162. Murphy BA, Cmelak A, Bayles S, et al. Palliative issues in the care of patients with cancer of the head and neck. In: Hanks G, Cherny N, Kaasa S, et al., editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010. p. 908–15.

    Google Scholar 

  163. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990;6:7–15.

    PubMed  CAS  Google Scholar 

  164. Harris A. Providing urinary continence care to adults at the end of life. Nurs Times. 2009;105:29.

    Google Scholar 

  165. Swann D, Edmonds P. The management of urinary symptoms. In: Sykes N, Edmonds P, Wiles J, editors. Management of advanced disease. 4th ed. London: Arnold; 2006. p. 219–24.

    Google Scholar 

  166. Gerber LH, Stout N. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. 2011;19:1581–91.

    Article  PubMed  Google Scholar 

  167. NHS Scotland. Fatigue. Available at: www.palliativecareguidelines.scot.nhs.uk/documents/Fatigue.pdf. Last accessed 27 Nov 2011.

  168. Mock V. Fatigue management. Evidence and guidelines for practice. Cancer. 2001;92:1699–707.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Zeppetella, G. (2012). Symptom Control. In: Palliative Care in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-4471-2843-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2843-4_4

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2842-7

  • Online ISBN: 978-1-4471-2843-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics